METHODICAL PECULIARITIES OF PRECLINICAL SAFETY ASSESSMENT OF DRUGS FOR CHILDREN

被引：0

|

作者：

MALTSEVA, LF

MURATOVA, GP

MOTOVILOVA, VG

SIRINOVA, NA

机构：

来源：

FARMAKOLOGIYA I TOKSIKOLOGIYA | 1988年 / 51卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：96 / 100

页数：5

相关论文

共 50 条

[1] Preclinical cardiac safety assessment of drugs
Hanton G.
[J]. Drugs in R & D, 2007, 8 (4) : 213 - 228
[2] PRECLINICAL ASSESSMENT OF ANTIARRHYTHMIC DRUGS
LUCCHESI, BR
LYNCH, JJ
[J]. FEDERATION PROCEEDINGS, 1986, 45 (08) : 2197 - 2205
[3] Symp VId Use of Ultrasound in Preclinical Hemodynamic and Safety Assessment of Investigational Drugs
DeFelice, Albert
[J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2011, 30 (01) : 122 - 122
[4] PRECLINICAL ASSESSMENT OF ABUSE LIABILITY OF DRUGS
KATZ, JL
GOLDBERG, SR
[J]. AGENTS AND ACTIONS, 1988, 23 (1-2): : 18 - 26
[5] METHODICAL FEATURES OF ASSESSMENT OF NATIONAL ECONOMIC EFFECTIVENESS OF DRUGS (AS A DISCUSSION)
SHEVCHENKO, AP
PODOLSKAYA, TN
VENEDIKTOVA, TS
VASILIEV, AI
[J]. KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1978, 12 (09): : 141 - 147
[6] ASSESSMENT OF SAFETY OF DRUGS
CAHAL, DA
[J]. BRITISH MEDICAL JOURNAL, 1966, 1 (5491): : 854 - &
[7] Modelling and Simulation for Preclinical Cardiac Safety Assessment of Drugs with Human iPSC-Derived Cardiomyocytes
Kügler P.
[J]. Jahresbericht der Deutschen Mathematiker-Vereinigung, 2020, 122 (4) : 209 - 257
[8] FAMOTIDINE - SUMMARY OF PRECLINICAL SAFETY ASSESSMENT
BUREK, JD
MAJKA, JA
BOKELMAN, DL
[J]. DIGESTION, 1985, 32 : 7 - 14
[9] Preclinical evaluation of the safety of drugs targeted for spinal delivery
Yaksh, TL
[J]. MANAGEMENT OF ACUTE AND CHRONIC PAIN: THE USE OF THE TOOLS OF THE TRADE, 2000, : 727 - 734
[10] METHODICAL PECULIARITIES OF ESTIMATING COMPETITIVENESS OF INDUSTRIAL ENTERPRISE
Zhamoida, O. A.
[J]. ACTUAL PROBLEMS OF ECONOMICS, 2009, (91): : 110 - 118

← 1 2 3 4 5 →